Target intelligence / Profile preview

Adenomatous Polyposis Coli (APC)

Target
APC
Molecular classification
Tumor Suppressor, Wnt signaling regulator, Other
01

Overview

The adenomatous polyposis coli protein serves as an essential tumor suppressor at both molecular signaling levels—primarily via negative regulation of Wnt/β-catenin—and broader cellular architecture maintenance. Its dysfunction underlies inherited syndromes like FAP as well as most sporadic cases of colon cancer through loss-of-function mutations disrupting these pathways.

Other names
DP2.5Deleted in polyposis 2.5
02

Mechanism of action

Wnt pathway modulation; induction of β-catenin degradation

03

Biological functions

Tumor suppressionNegative regulator of Wnt/β-catenin pathwayCell cycle controlCytoskeleton organizationCell adhesionCell migrationRegulation of gene expressionImmune response
04

Disease associations

Familial adenomatous polyposis (FAP)Colorectal cancerCancer
05

Safety considerations

Potential for off-target effects in Wnt signalingComplex role in multiple cellular processes
06

Biomarkers

APC mutations in tumor tissueAPC mutations in germline DNA

Beyond the preview

Go deeper on Adenomatous Polyposis Coli (APC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adenomatous Polyposis Coli (APC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call